Mochida Pharmaceutical Competitors and Similar CompaniesClear all

Mochida Pharmaceutical's competitors and similar companies include CSPC Pharmaceutical Group, Sanofi Pasteur, McKesson Europe and Joincare.

	Mochida Pharmaceutical Mochida Pharmaceutical (持田製薬株式) is a company providing pharmaceutical products.	CSPC Pharmaceutical Group CSPC Pharmaceutical Group (石药集团有限公司) is a pharmaceutical company engaged in drug development and production.	Sanofi Pasteur Sanofi Pasteur is a pharmaceutical company that develops, manufactures, and supplies vaccines.	McKesson Europe McKesson Europe is a trading company that provides logistics and services in the pharmaceutical and healthcare sector.	Joincare Joincare (健康元药业集团股份有限公司) is a company that manufactures and supplies pharmaceuticals products.
Founding Date	Founding Date 1913	Founding Date N/A	Founding Date 1989	Founding Date 1835	Founding Date 1992
Type	Type Public	Type Public	Type Subsidiary	Type Subsidiary	Type Public
Tags	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma
Locations	Locations Shinjuku City, JP HQ	Locations Shijiazhuang, CN HQ Hong Kong, HK	Locations Lyon, FR HQ	Locations Stuttgart, DE HQ	Locations Shen Zhen, CN HQ
Employees	Employees 1,522	Employees 21,4005% increase	Employees 6,7454% increase	Employees 26,329	Employees 14,350
Valuation ($)	Valuation ($) 790.2 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 3 b
Financial
Revenue (est.)	Revenue (est.) ¥105.2b (FY, 2025)	Revenue (est.) ¥26b (FY, 2025)	Revenue (est.) €2.8b (FY, 2021)	Revenue (est.) €18b (FY, 2022)	Revenue (est.) ¥14.9b (FY, 2025)
Cost of goods	Cost of goods ¥48.4b (FY, 2025)	Cost of goods ¥7.5b (FY, 2025)	Cost of goods €505m (FY, 2021)	Cost of goods €16.1b (FY, 2022)	Cost of goods ¥5.7b (FY, 2025)
Gross profit	Gross profit ¥56.7b (FY, 2025)	Gross profit ¥19b (FY, 2025)	Gross profit €2.3b (FY, 2021)	Gross profit €1.9b (FY, 2022)	Gross profit ¥9.3b (FY, 2025)
Net income	Net income ¥5.7b (FY, 2025)	Net income ¥3.9b (FY, 2025)	Net income €605m (FY, 2021)	Net income (€867.4m) (FY, 2022)	Net income ¥2.9b (FY, 2025)